UBP1 and malaria: UBP-1 mutations could, therefore, be an independent avenue by which ART or multidrug resistance phenotypes could emerge in regions where malaria is endemic, as has been seen in Africa (Ghana and Kenya), without actually requiring a permissive genetic background, as seems to be the current landscape with Kelch-13 mutations.